Science Translational Medicine

Article	Citations
Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice	434
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR -mutant lung cancer	371
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting	367
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine	345
Erratum for the Research Article: “Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis” by M. Scherlinger, V. Guillotin, I. Douchet, P. Vacher, A. B	284
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant	283
Stronger regulation of AI in biomedicine	223
Advancing beyond the twists and turns of T cell exhaustion in cancer	205
A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care	204
A tale of two cells: Regulatory T cell–microglia cross-talk in the ischemic brain	201
Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics	194
Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment	191
Antigenic distance between primary and secondary dengue infections correlates with disease risk	187
Transcriptome-based identification of tumor-reactive and bystander CD8 + T cell receptor clonotypes in human pancreatic cancer	185
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes	182
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors	179
TrkA-mediated sensory innervation of injured mouse tendon supports tendon sheath progenitor cell expansion and tendon repair	178
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemia	177
Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease	175
Engineering CAR-T therapies for autoimmune disease and beyond	169
Increased brain microvascular hemoglobin concentrations in children with cerebral malaria	165
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment	163
SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 + T cells	163
Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome	162
AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer	159

A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification	158
The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England	155
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies	153
Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms	152
Evolution of inflammation and immunity in a dengue virus 1 human infection model	151
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy	150
Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection	134
In vivo gene immunotherapy for cancer	134
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer	134
Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer	133
Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation	132
Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging	132
A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens	127
Point-of-care diagnostic tests for tuberculosis disease	126
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery	125
Erratum for the Research Article: “The Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis” by S. S. Pullamsetti, R. Savai, R. Dumitrascu, B. K. Dahal, J. Wilhelm, M. Koni	122
Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager	122
Translating insights into therapies for Long Covid	118
Development and preclinical validation of 2-deoxy 2-[ 18 F]fluorocellobiose as an Aspergillus -specific PET tracer	118
NAD + precursors and bile acid sequestration treat preclinical refractory environmental enteric dysfunction	117
Integrating the gut microbiome and pharmacology	115
Next-generation CAR T cell therapies for glioblastoma	114
Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation	113
Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors	113
Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection	112
Improved control of a prosthetic limb by surgically creating electro-neuromuscular constructs with implanted electrodes	112
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models	110
The pancreatic clock is a key determinant of pancreatic fibrosis progression and exocrine dysfunction	109
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer’s disease	108
Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas	106
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron	105
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis	105
TREM1 activation of myeloid cells promotes antitumor immunity	105
A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility	105
Nociceptor-to-macrophage communication through CGRP/RAMP1 signaling drives endometriosis-associated pain and lesion growth in mice	105
BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease	105
Volumetric microscopy of cerebral arteries with a miniaturized optical coherence tomography imaging probe	101
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia	100
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy	100
Disrupting mechanotransduction decreases fibrosis and contracture in split-thickness skin grafting	100
Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons	99
The oncomodulin receptor ArmC10 enables axon regeneration in mice after nerve injury and neurite outgrowth in human iPSC–derived sensory neurons	99
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis	98
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer	98
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)	97
Sexually dimorphic differences in angiogenesis markers are associated with brain aging trajectories in humans	97
Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation	97
Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models	97
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa	96
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants	95

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy	95
Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors	94
AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific T H 1 response with a diverse TCR repertoire	94
Diet shapes the metabolite profile in the intact human ileum, which affects PYY release	94
Apelin stimulation of the vascular skeletal muscle stem cell niche enhances endogenous repair in dystrophic mice	93
Na v 1.7 target modulation and efficacy can be measured in nonhuman primate assays	93
Wastewater surveillance facilitates climate change–resilient pathogen monitoring	92
Assessment of cholesterol homeostasis in the living human brain	92
A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis	91
An oral antisense oligonucleotide for PCSK9 inhibition	91
A nose for tau	91
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort	91
Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration	90
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment	90
Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis	90
Tobacco smoke exposure recruits inflammatory airspace monocytes that establish permissive lung niches for Mycobacterium tuberculosis	89
Innate PD-L1 limits T cell–mediated adipose tissue inflammation and ameliorates diet-induced obesity	89
Multicellular modeling of ciliopathy by combining iPS cells and microfluidic airway-on-a-chip technology	88
T cell receptor precision editing of regulatory T cells for celiac disease	88
Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model	88
Repeated Plasmodium falciparum infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire	88
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial	87
Short-course combination treatment for experimental chronic Chagas disease	86
An ACE inhibitor reduces bactericidal activity of human neutrophils in vitro and impairs mouse neutrophil activity in vivo	85
Transcriptomic sex differences in postmortem brain samples from patients with psychiatric disorders	84
Postoperative adhesions are abrogated by a sustained-release anti-JUN therapeutic in preclinical models	84
Obesity and lifespan, a complex tango	84
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease	83
Adaptive cognitive control circuit changes associated with problem-solving ability and depression symptom outcomes over 24 months	83
Transient receptor potential canonical 5 mediates inflammatory mechanical and spontaneous pain in mice	82
Harnessing regulatory T cells to establish immune tolerance	82
mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria	81
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria	81
CD23 + IgG1 + memory B cells are poised to switch to pathogenic IgE production in food allergy	81
Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes	81
Erratum for the Research Article “A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer” by A. M. Miller et al<	80
Sex, lean body mass, and cardiac performance	80
Comment on “Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI”	79
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases	79
Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice	79
Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice	78
Response to comment on “Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI”	78
Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized mice	77
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia	77
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria	77
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice	76
Immune responses to gut bacteria associated with time to diagnosis and clinical response to T cell–directed therapy for type 1 diabetes prevention	76
Collagen V regulates renal function after kidney injury and can be pharmacologically targeted to enhance kidney repair in mice	76
Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia	76
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis	75
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection	74
Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease	74
Green light analgesia in mice is mediated by visual activation of enkephalinergic neurons in the ventrolateral geniculate nucleus	74
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers	74
Tissue-resident CD8 + T cells drive compartmentalized and chronic autoimmune damage against CNS neurons	73
Modeling injury and repair in kidney organoids reveals that homologous recombination governs tubular intrinsic repair	73
Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction	72
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models	72
IgE in allergy: It takes two	72
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer	71
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection	71
Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation	70
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice	70
T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models	70
Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection	69
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis	68
Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis	68
Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing	68
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans	67
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response	67
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor	67
Targeting cytokines in inflammatory bowel disease	67
A cell-penetrant peptide blocking C9ORF72 -repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins	66
Erratum for the Research Article: “Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses” by E. A. Bordt, L. L. Shook, C. Atyeo, K. M. Pullen, R. M. De Guzman, M.-C. Mein	66
MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases	66
Gastric dysfunction in patients with chronic nausea and vomiting syndromes defined by a noninvasive gastric mapping device	66
Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy	66
Comment on “A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk”	66
Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases	65
Genipin rescues developmental and degenerative defects in familial dysautonomia models and accelerates axon regeneration	65

Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant–associated infections	65
An AAV gene therapy computes over multiple cellular inputs to enable precise targeting of multifocal hepatocellular carcinoma in mice	65
Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging	64
Erratum for the Research Article “Platelet-derived growth factor C signaling is a potential therapeutic target for radiation proctopathy” by W. Lu et al .	64
In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis	64
Erratum for the Research Article “Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4” by Y. Ren et al .	64
Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models	63
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers	63
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6	63
Spatial genomics: Mapping the landscape of fibrosis	63
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis	63
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics	63
Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice	63
New government drug repurposing programs: Opportunities and uncertainties	63
CD4 + T cells are essential for the development of destructive thyroiditis induced by anti–PD-1 antibody in thyroglobulin-immunized mice	63
Identifying and targeting the Achilles heel of a recalcitrant cancer	62
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma	62
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease	62
Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models	61
Allergy: Mechanistic insights into new methods of prevention and therapy	61
NF-κB perturbation reveals unique immunomodulatory functions in Prx1 + fibroblasts that promote development of atopic dermatitis	61
Neuromodulation using ultra low frequency current waveform reversibly blocks axonal conduction and chronic pain	61
Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age–related tauopathy and Alzheimer’s disease	61
Prostate tissue ablation and drug delivery by an image-guided injectable ionic liquid in ex vivo and in vivo models	61
Resident microbes shape the vaginal epithelial glycan landscape	60
Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice	60
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity	60
Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants	60
Interleukin-2–based therapies in cancer	60
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer	60
Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due toTTNmutations	60
Seeking satiety: From signals to solutions	59
Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology	59
Delivery of therapeutic carbon monoxide by gas-entrapping materials	59
Gut pathogen colonization precedes bloodstream infection in the neonatal intensive care unit	59
Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer’s disease	58
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection	58
A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos	58
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer	57
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19	57
JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models	57
Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease	57
Neuroinflammation: An astrocyte perspective	57
Response to Comment on “Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases”	56
An anti-mycobacterial conjugated oligoelectrolyte effective against Mycobacterium abscessus	56
Response to comment on “Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics”	56
Erratum for the Research Article “Boosting systemic absorption of peptides with a bioinspired buccal-stretching patch,” by Z. Luo et al .	56
A prM mutation that attenuates dengue virus replication in human cells enhances midgut infection in mosquitoes	56
Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected	56
Predicting the next round of drugs for Medicare price negotiation	55
Where do the pathogens that cause surgical site infections come from?	55
Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy	54
A mouse model of chronic primary pain that integrates clinically relevant genetic vulnerability, stress, and minor injury	54
Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity	54
GABABreceptor modulation of visual sensory processing in adults with and without autism spectrum disorder	54
Chemogenetics identifies separate area 25 brain circuits involved in anhedonia and anxiety in marmosets	54
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques	53
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses	53
Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human	53
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19	53
Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19	53
Functional human IgA targets a conserved site on malaria sporozoites	52
Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis	52
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model	52
Learning CNS immunopathology from therapeutic interventions	52
Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease	52
Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a spliceosome kinase	52
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer	51
Glutamine promotes antibiotic uptake to kill multidrug-resistant uropathogenic bacteria	51
Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis	51
Provocateurs of autoimmunity within the gut microbiota	51
Neuronal population activity in the olivocerebellum encodes the frequency of essential tremor in mice and patients	51
Activation and antitumor immunity of CD8 + T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid	51
Alpelisib administration reduced lymphatic malformations in a mouse model and in patients	51
Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy	51
A semaphorin-plexin-Rasal1 signaling pathway inhibits gastrin expression and protects against peptic ulcers	50
Protein kinase Cι mediates immunosuppression in lung adenocarcinoma	50
Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem–specific human B cells	50
Donor-derived regulatory dendritic cell infusion modulates effector CD8+T cell and NK cell responses after liver transplantation	50
Visualization of exhaled breath metabolites reveals distinct diagnostic signatures for acute cardiorespiratory breathlessness	49
The protein kinase C modulator bryostatin-1 therapeutically targets microglia to attenuate neuroinflammation and promote remyelination	49
A new chapter in lipid signaling and kidney fibrosis	49
Transient anti-interferon autoantibodies in the airways are associated with recovery from COVID-19	49
Myeloid cell–specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease	49
An identity crisis for lung cancer cells	49
Keratinocytes: From passive targets to active mediators of systemic autoimmunity	49
Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”	49
Erratum for the Research Article “Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia” by R. Sartori et al .	48
Bone morphogenetic protein 9 is a candidate prognostic biomarker and host-directed therapy target for sepsis	48
Vaccines for a sustainable planet	48
Targeting the PDE3B-cAMP-autophagy axis prevents liver injury in long-term supercooling liver preservation	48
Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy	48
Pathophysiology of Dyt1- Tor1a dystonia in mice is mediated by spinal neural circuit dysfunction	48
Epicardial differentiation drives fibro-fatty remodeling in arrhythmogenic cardiomyopathy	48
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML	47